Literature DB >> 27651251

Efficacy of Natural Compounds in Neurodegenerative Disorders.

Pranay Srivastava1, Rajesh Singh Yadav2.   

Abstract

Neurodegenerative disorders represent clusters of serious diseases that results in progressive deterioration of normal structure and physiology of central nervous system. Pathophysiology of Alzheimer's, Parkinson's or other neurodegenerative disorders involves multifaceted permutation of genetic and environmental factors. Combinations of lifestyle modification linked with environmental factor jointly or alone represent the largest share of cases of these disorders. Etiology of such neuronal degeneration involves manifestation of toxic reaction in the form of functional anomalies leading to dysfunction of the ubiquitin-proteasome system, activated inflammatory cascade, compromised neuronal survival pathway, mitochondrial dysfunction and finally neuronal apoptosis/necrosis and cell death. Furthermore, evidences from various studies exhibited role of oxidative stress and compromised anti-oxidant defense system as one of the prime factors associated with activation of various signal transduction pathways that would ultimately lead to the formation of amyloid beta or alpha synuclein in the brain. Keeping in view of complex etiology and pathophysiology along with a miniscule of available treatment options associated with these neurodegenerative disorders, the role of natural agents and herbal extracts as therapeutic alternatives alone or in combination with synthetic drugs could not be ruled out. In the same context the present chapter has been aimed to investigate the role of selected natural plants like Withania somnifera, Bacopa monnieri, Curcuma longa, Centella asiatica, Ocimum sanctum, Nardostachys jatamansi and Emblica officinalis in various neurodegenerative disorders and explore their targets to ameliorate neurotoxicity in various experimental models. The rationale for selection of these plants was based on their strong anti-inflammatory and anti-oxidant potential and large body of evidence that suggest their efficacy in preclinical as well as in clinical studies. Active constituents if these herbals might play an important role in preserving the integrity of various neurotransmitters and their receptor in the brain influencing its functions at the molecular level.

Entities:  

Keywords:  Alzheimer’s disease; Herbal agents; Neurodegeneration; Neurotoxicity; Parkinson’s disease

Mesh:

Substances:

Year:  2016        PMID: 27651251     DOI: 10.1007/978-3-319-28383-8_7

Source DB:  PubMed          Journal:  Adv Neurobiol


  5 in total

1.  In Vitro Screening for Cytotoxic Activity of Herbal Extracts.

Authors:  Valter R M Lombardi; Iván Carrera; Ramón Cacabelos
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-13       Impact factor: 2.629

2.  16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics.

Authors:  Christine Tara Peterson; Vandana Sharma; Stanislav N Iablokov; Levent Albayrak; Kamil Khanipov; Sasha Uchitel; Deepak Chopra; Paul J Mills; Yuriy Fofanov; Dmitry A Rodionov; Scott N Peterson
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

3.  SIRT3 Regulation of Mitochondrial Quality Control in Neurodegenerative Diseases.

Authors:  Hao Meng; Wan-Yu Yan; Yu-Hong Lei; Zheng Wan; Ye-Ye Hou; Lian-Kun Sun; Jue-Pu Zhou
Journal:  Front Aging Neurosci       Date:  2019-11-12       Impact factor: 5.750

4.  Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP+-Induced Toxicity via Progesterone Receptor Signaling.

Authors:  Yingke Zhao; Jia Zhao; Xiuying Zhang; Yuanyuan Cheng; Dan Luo; Simon Ming-Yuen Lee; Lixing Lao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2020-10-17       Impact factor: 6.543

5.  The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer's Disease: A Transcriptomic Study.

Authors:  Serena Silvestro; Luigi Chiricosta; Agnese Gugliandolo; Renato Iori; Patrick Rollin; Daniele Perenzoni; Fulvio Mattivi; Placido Bramanti; Emanuela Mazzon
Journal:  Curr Issues Mol Biol       Date:  2021-05-26       Impact factor: 2.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.